{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_52582"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_52582","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"MOLECULAR MECHANISMS OF OBESITY-DRIVEN CARCINOGENESIS : IMPLICATIONS FOR SKIN CANCER AND MULTIPLE MYELOMA","abstract":"Thesis (Ph.D.)--Michigan State University. Pharmacology and Toxicology-Environmental Toxicology - Doctor of Philosophy, 2025","abstract_html":"Thesis (Ph.D.)--Michigan State University. Pharmacology and Toxicology-Environmental Toxicology - Doctor of Philosophy, 2025","abstract_has_math":false,"creators":["Yawson, Nat Ato"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Bernard, Jamie J","Luyendyk, James","Neubig, Richard","Edmund, Ellsworth"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025","date_published":"2025","updated_at":"2026-11-18T18:59:09Z","subjects":["Pharmacology"],"languages":["eng"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52582","local:Yawson_grad.msu_0128D_21540"],"render_values":[{"text":"etd:52582","href":null,"code":true},{"text":"local:Yawson_grad.msu_0128D_21540","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/zjgr-z265","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/zjgr-z265","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_52582","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Bernard, Jamie J","Luyendyk, James","Neubig, Richard","Edmund, Ellsworth"]},{"key":"dc:creator","label":"Author","values":["Yawson, Nat Ato"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2025"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Pharmacology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:52582","local:Yawson_grad.msu_0128D_21540","https://doi.org/doi:10.25335/zjgr-z265"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Pharmacology and Toxicology-Environmental Toxicology - Doctor of Philosophy, 2025","The National Cancer Institute defines cancer as a disease characterized by the uncontrolled proliferation of cells that can invade and spread to other parts of the body. In 2022, around 20 million new cancer cases were recorded worldwide, and estimates indicate this figure may increase to 29.9 million in 2040. The etiology of cancer is multifactorial and afflicts many tissue types, causing millions of deaths worldwide. Therefore, it is imperative to develop novel drugs for both prevention and treatment. Obesity is a risk factor for several types of cancer, including breast, prostate, and colon cancer and contributes to disease progression. However, the influence of obesity on the development of nonmelanoma skin cancer (NMSC), the most common type of cancer, remains unclear. The first objective of this dissertation is to understand how obesity may contribute to the development of NMSC, specifically the transformation of benign actinic keratosis into potentially invasive cutaneous squamous cell carcinoma. RNA-Seq analysis of a cell line identified Angiopoietin-like 4 (ANGPTL4) as a potential target of adipocyte-secreted factors in keratinocytes that support growth. Immunohistochemistry staining of lesional skin biopsies revealed that ANGPTL4 is linked to the early stages of NMSC development, with high levels expressed in actinic keratosis and cutaneous squamous carcinoma in situ. The protein was absent in the keratinocytes within the invasive squamous cell carcinoma, suggesting the early role of this protein in NMSC development. These data suggest that targeting ANGPTL4 may offer a novel therapy for preventing the progress of NMSC. Additionally, patients with high ANGPTL4 levels or those with obesity may represent a critical demographic for risk assessment and therapeutic intervention. The second objective of this dissertation is to identify novel compounds that could be developed into drugs for multiple myeloma. Multiple myeloma is a cancer associated with obesity that is currently incurable because patients become refractory to treatments. Through a phenotypic and target-based screening approach, some compounds were identified that can be optimized for the treatment of multiple myeloma. The first compound, MSU-43222, proved effective against dexamethasone-resistant multiple myeloma cell lines, with low toxicity observed in peripheral blood mononuclear cells (PBMC). The second group of compounds, which were GPR68 inhibitors (OGM1, R, and R17 significantly decreased the viability of human multiple myeloma cell lines (MM.1S cells). They also induced the expression of ferroptosis-related genes (ATF4, CHAC1, and SLC7A11) and increased lipid peroxide levels in MM.1S cells. These GPR68 inhibitors provide an alternative approach to targeting apoptosis-resistant multiple myeloma patients. Overall, this thesis reveals promising approaches for therapeutic interventions in preventing and treating obesity-related cancers, including NMSC and multiple myeloma.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (132 p.) : ill."]},{"key":"dc:title","label":"Title","values":["MOLECULAR MECHANISMS OF OBESITY-DRIVEN CARCINOGENESIS : IMPLICATIONS FOR SKIN CANCER AND MULTIPLE MYELOMA"]}]}],"canonical_facts":{"dc:contributor":["Bernard, Jamie J","Luyendyk, James","Neubig, Richard","Edmund, Ellsworth"],"dc:creator":["Yawson, Nat Ato"],"dc:date":["2025"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Pharmacology and Toxicology-Environmental Toxicology - Doctor of Philosophy, 2025","The National Cancer Institute defines cancer as a disease characterized by the uncontrolled proliferation of cells that can invade and spread to other parts of the body. In 2022, around 20 million new cancer cases were recorded worldwide, and estimates indicate this figure may increase to 29.9 million in 2040. The etiology of cancer is multifactorial and afflicts many tissue types, causing millions of deaths worldwide. Therefore, it is imperative to develop novel drugs for both prevention and treatment. Obesity is a risk factor for several types of cancer, including breast, prostate, and colon cancer and contributes to disease progression. However, the influence of obesity on the development of nonmelanoma skin cancer (NMSC), the most common type of cancer, remains unclear. The first objective of this dissertation is to understand how obesity may contribute to the development of NMSC, specifically the transformation of benign actinic keratosis into potentially invasive cutaneous squamous cell carcinoma. RNA-Seq analysis of a cell line identified Angiopoietin-like 4 (ANGPTL4) as a potential target of adipocyte-secreted factors in keratinocytes that support growth. Immunohistochemistry staining of lesional skin biopsies revealed that ANGPTL4 is linked to the early stages of NMSC development, with high levels expressed in actinic keratosis and cutaneous squamous carcinoma in situ. The protein was absent in the keratinocytes within the invasive squamous cell carcinoma, suggesting the early role of this protein in NMSC development. These data suggest that targeting ANGPTL4 may offer a novel therapy for preventing the progress of NMSC. Additionally, patients with high ANGPTL4 levels or those with obesity may represent a critical demographic for risk assessment and therapeutic intervention. The second objective of this dissertation is to identify novel compounds that could be developed into drugs for multiple myeloma. Multiple myeloma is a cancer associated with obesity that is currently incurable because patients become refractory to treatments. Through a phenotypic and target-based screening approach, some compounds were identified that can be optimized for the treatment of multiple myeloma. The first compound, MSU-43222, proved effective against dexamethasone-resistant multiple myeloma cell lines, with low toxicity observed in peripheral blood mononuclear cells (PBMC). The second group of compounds, which were GPR68 inhibitors (OGM1, R, and R17 significantly decreased the viability of human multiple myeloma cell lines (MM.1S cells). They also induced the expression of ferroptosis-related genes (ATF4, CHAC1, and SLC7A11) and increased lipid peroxide levels in MM.1S cells. These GPR68 inhibitors provide an alternative approach to targeting apoptosis-resistant multiple myeloma patients. Overall, this thesis reveals promising approaches for therapeutic interventions in preventing and treating obesity-related cancers, including NMSC and multiple myeloma.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (132 p.) : ill."],"dc:identifier":["etd:52582","local:Yawson_grad.msu_0128D_21540","https://doi.org/doi:10.25335/zjgr-z265"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Pharmacology"],"dc:title":["MOLECULAR MECHANISMS OF OBESITY-DRIVEN CARCINOGENESIS : IMPLICATIONS FOR SKIN CANCER AND MULTIPLE MYELOMA"],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:59:09Z"}